Literature DB >> 23489219

Reversible cerebral vasoconstriction syndrome.

Holly Yancy1, Joyce K Lee-Iannotti, Todd J Schwedt, David W Dodick.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium-channel blockers, as there are no controlled treatment trials for RCVS. Randomized controlled trials are needed.
© 2013 American Headache Society.

Entities:  

Mesh:

Year:  2013        PMID: 23489219     DOI: 10.1111/head.12040

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

Review 1.  Reversible cerebral vasoconstriction syndrome: updates and new perspectives.

Authors:  Huma U Sheikh; Paul G Mathew
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 2.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 3.  Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.

Authors:  Yuji Kato; Takeshi Hayashi; Satoko Mizuno; Yohsuke Horiuchi; Masayuki Ohira; Norio Tanahashi; Masaki Takao
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.